Author:
Niu Xianli,Nong Shirong,Gong Junyuan,Zhang Xin,Tang Hui,Zhou Tianhong,Li Wei
Funder
AIDS and viral hepatitis and other major infectious disease prevention and control, National Science and technology major projects, sub topics New target research on anti HBV treatment
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Yang XZ, Gen AW, Xian JC, Xiao L (2018) Diagnostic value of various noninvasive indexes in the diagnosis of chronic hepatic fibrosis. Eur Rev Med Pharmacol Sci 22(2):479–485
2. Bilezikçi B, Haberal AN, Demirhan B (2016) Hepatocyte growth factor in patients with three different stages of chronic liver disease including hepatocellular carcinoma, cirrhosis and chronic hepatitis: an immunohistochemical study. 15(3):159
3. Ge L, Shi B, Song YE, Li Y, Wang S, Wang X (2015) Clinical value of real-time elastography quantitative parameters in evaluating the stage of liver fibrosis and cirrhosis. Exp Ther Med 10(3):983–990
4. Xinguang Y, Huixing Y, Linlin W, Wanxin W, Xiaojun W, Linghua Y (2016) RSPOs facilitated HSC activation and promoted hepatic fibrogenesis. Oncotarget. 7(39):63767–63778
5. Wu K, Ye C, Lin L et al (2016) Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT. Clin Sci (Lond) 130(16):1469–1480
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献